Author's posts
Pro-Vaccination Message Should Be Apolitical, As NYT Argues But Fails To Demonstrate
Vaccination is a critically important public health measure. Anti-vaccination disinformation needs to be countered in a non-political fashion, as the NYT Editorial Board argues but fails to demonstrate.
Novartis CEO Who Wanted To Bring Tech Into Pharma Now Explains Why It’s So Hard
We need to bring our best technology – biological and digital – and our most creative people together to work on this monumental challenge. One clear take-away from the Narasimhan interview: pharma is at the very earliest stages of figuring out how to…
What I learned Losing 80 Pounds In 2018
A dream would be to attain my goal weight and then develop the routine to maintain it, so I wouldn’t need to worry about falling off the wagon every single day. I doubt this is realistic. More likely, successful long-term weight loss will require cons…
Data Scientist Explains How AI’s Seductive Power Can Mislead Biomarker Researchers
Translating AI approaches to contemporary challenges in clinical diagnosis is not just difficult, but really tricky; the most significant challenge may well be that the power of AI permits us to convince ourselves we’ve found something *significant*, b…
Aural Pleasures — 2018 Edition
My current favorite podcasts — and audiobooks — for healthcare innovators.
We Are Not A Dashboard: Contesting The Tyranny Of Metrics, Measurement, And Managerialism
Data sciences and technology could, and must, play a vital role. But they haven’t earned the right to be considered an end in themselves. They represent potentially valuable tools, ideally in the hands of experienced, inquisitive practitioners, who uni…
Shuttered Magazine Editor Struggles With Collaboration Lesson Health Data Advocates Sadly Learned
A conservative editor is mugged by reality; health data advocates would have been far less surprised.
Amy Abernethy: Poised To Propel FDA Into Tech-Savvy, Patient-Centric Future
As our focus expands from approvals to outcomes, fluency with real-world data, and the tools to generate and analyze this information, will be ever-more critical. Amy Abernethy has the right experience, attributes, and instincts to catalyze the FDA’s …
AI Doesn’t Ask Why — But Physicians And Drug Developers Want To Know
AI relates often imperceptible observations to outcome in a fashion that’s unapologetically oblivious to mechanism, which challenges physicians and drug developers by explicitly severing utility from foundational scientific understanding.
California’s New Diversity Law Aims To Help Businesses Help Themselves
The reason diversity works — the “speedbump effect” — may also relate to why it’s challenging for some businesses to adopt, as the efficiencies of homogeneity can be alluring. New legislation in California aims to nudge companies towards greater gen…
